Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06357702 · ClinicalTrials.gov registry record · NA
K23- Physical Self Regulation vs Placebo
A NA study of Temporomandibular Disorder, sponsored by Ian Boggero, PhD.
- Recruiting
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT06357702: Recruiting NA study of Temporomandibular Disorder, sponsored by Ian Boggero, PhD.
NCT06357702 is a NA study of Temporomandibular Disorder that is actively recruiting participants, run by Ian Boggero, PhD. The registered enrollment target is 104 participants, below the 122-participant average among 3 other Temporomandibular Disorder trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06357702, a NA study of Temporomandibular Disorder, is actively recruiting participants, sponsored by Ian Boggero, PhD.
- RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use a between-person design. Participants will be treatment-seeking patients with chronic masticatory muscle pain. Participants who are eligible for the study and consent to participate will be randomly assigned to receive a brief behavioral intervention for chronic orofacial pain called Physical Self-Regulation or a control intervention. Interventions will be administered via telehealth in both arms. Both interventions will consist of 2 50-minute sessions scheduled approximately two weeks apart. Participants will be contacted two weeks and three months after completing the interventions to provide additional follow-up data. Investigators hypothesize that both PSR-TH and the control intervention will demonstrate strong feasibility (i.e., recruitment of at least 1 participant per week, \>75% retention, \>95% interventionist fidelity, and adequate acceptability, credibility, and burden). Investigators also hypothesize that specific biopsychosocial variables will moderate PSR-TH-related changes in outcomes, and that PSR-TH-related changes in perceived control over pain, self-efficacy, coping, parafunctional habits, and relaxation will mediate treatment effects.
Primary Outcome
Pain intensity will be measured with the Graded Chronic Pain Scale Pain Intensity Subscale. Participants rate their worst pain, least pain, average pain, in the last 24 hours and pain right now using an 11 point Likert scale ranging from 0 to 10 with higher scores equating to greater pain. Scores are averaged for the total pain intensity score.
Conditions Studied
Interventions
- BEHAVIORAL Physical Self Regulation Telehealth
- BEHAVIORAL Psycho-education Telehealth
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2024-04-04 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What NCT06357702 shows while recruiting
NCT06357702 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 122-participant average among 3 other Temporomandibular Disorder trials with a reported enrollment target (15% lower).
The record links to 1 condition, with Temporomandibular Disorder appearing as the primary indexed condition, and to 2 interventions - of which Physical Self Regulation Telehealth is the first listed.
NCT06357702 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06357702 about?
NCT06357702 is a clinical study titled "K23- Physical Self Regulation vs Placebo". This study will use a between-person design. Participants will be treatment-seeking patients with chronic masticatory muscle pain. Participants who are eligible for the study and consent to participate will be randomly assigned to receive a brief behavioral intervention for chronic orofacial pain ca...
What is the current status of trial NCT06357702?
This trial is currently recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2024-04-04. Estimated completion is 2028-08-31.
What conditions does trial NCT06357702 study?
This clinical trial studies the following conditions: Temporomandibular Disorder.
What interventions are being tested in trial NCT06357702?
The interventions under investigation include: Physical Self Regulation Telehealth (BEHAVIORAL), Psycho-education Telehealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT06357702?
This trial is sponsored by Ian Boggero, PhD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06357702 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Temporomandibular Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI